Quoin Pharmaceuticals annual capital expenditures (capex)
2017
2019
2020
2021
2022
Quoin Pharmaceuticals Capital Expenditures (CapEx) Growth & History (QNRX)
Quoin Pharmaceuticals's capital expenditures (capex) was $250,000 for fiscal 2022.
View full Quoin Pharmaceuticals company overviewQuoin Pharmaceuticals annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2022 | 2022-12-31 | $250,000 | −$375,000 | −60.00% |
| 2021 | 2021-12-31 | $625,000 | $522,000 | +506.80% |
| 2020 | 2020-12-31 | $103,000 | $67,000 | +186.11% |
| 2019 | 2019-12-31 | $36,000 | — | — |
| 2017 | 2017-12-31 | $77,000 | — | — |
Quoin Pharmaceuticals capital expenditures (capex) trends
Over the last five fiscal years, Quoin Pharmaceuticals's capital expenditures (capex) increased from $77,000 to $250,000, a change of $173,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Quoin Pharmaceuticals source filings ↗